ZYNE Annual Total Long Term Liabilities
$119.50 K
-$234.20 K-66.21%
31 December 2022
Summary:
As of January 21, 2025, ZYNE annual total long term liabilities is $119.50 thousand, with the most recent change of -$234.20 thousand (-66.21%) on December 31, 2022. During the last 3 years, it has risen by +$9800.00 (+8.93%).ZYNE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Quarterly Long Term Liabilities
$0.00
-$60.00 K-100.00%
30 June 2023
Summary:
As of January 21, 2025, ZYNE quarterly total long term liabilities is $0.00, with the most recent change of -$60.00 thousand (-100.00%) on June 30, 2023. Over the past year, it has dropped by -$237.40 thousand (-100.00%).ZYNE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -66.2% | -100.0% |
3 y3 years | +8.9% | 0.0% |
5 y5 years | -82.0% | -100.0% |
ZYNE Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -99.3% | -100.0% |
Zynerba Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $0.00(-100.0%) |
Mar 2023 | - | $60.00 K(-49.8%) |
Dec 2022 | $119.50 K(-66.2%) | $119.50 K(-33.1%) |
Sept 2022 | - | $178.70 K(-24.7%) |
June 2022 | - | $237.40 K(-19.7%) |
Mar 2022 | - | $295.80 K(-16.4%) |
Dec 2021 | $353.70 K(>+9900.0%) | $353.70 K(-14.0%) |
Sept 2021 | - | $411.20 K(-12.2%) |
June 2021 | - | $468.40 K(-10.8%) |
Mar 2021 | - | $525.10 K(>+9900.0%) |
Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2020 | - | $0.00(0.0%) |
June 2020 | - | $0.00(-100.0%) |
Mar 2020 | - | $44.20 K(-59.7%) |
Dec 2019 | $109.70 K(>+9900.0%) | $109.70 K(>+9900.0%) |
Sept 2019 | - | $0.00(0.0%) |
June 2019 | - | $0.00(-100.0%) |
Mar 2019 | - | $20.60 K(>+9900.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(-100.0%) |
June 2018 | - | $834.00 K(+26.0%) |
Mar 2018 | - | $662.00 K(0.0%) |
Dec 2017 | $662.00 K(>+9900.0%) | $662.00 K(>+9900.0%) |
Sept 2017 | - | $0.00(0.0%) |
June 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(-100.0%) |
Sept 2016 | - | $463.40 K(>+9900.0%) |
June 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2015 | - | $0.00(-100.0%) |
June 2015 | - | $16.52 M(>+9900.0%) |
Mar 2015 | - | $0.00(-100.0%) |
Dec 2014 | $16.52 M(+1005.1%) | $16.52 M |
Dec 2013 | $1.50 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Zynerba Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Zynerba Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ZYNE is $119.50 K
What is the all time high annual total long term liabilities for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual total long term liabilities is $16.52 M
What is Zynerba Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ZYNE annual total long term liabilities has changed by -$234.20 K (-66.21%)
What is Zynerba Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ZYNE is $0.00
What is the all time high quarterly long term liabilities for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly total long term liabilities is $16.52 M
What is Zynerba Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ZYNE quarterly total long term liabilities has changed by -$237.40 K (-100.00%)